Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920305
Event date: 2026-10-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Funk, Stephen P.
Shares: 91,570.00 · Class: 5.8%
- Alta Investments LLC
Shares: 74,345.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001626109-26-000005
- Form type
- SCHEDULE 13G
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- Nov 05, 2026
- Reporting period
- Oct 06, 2026
- Description
- Schedule 13G beneficial ownership